Dier Mardi
- SEC CIK
- 0001574591
In the past year, 3 open-market sale filings worth $3.77M and no purchases.
Current role at each company
- MDGL Madrigal Pharmaceuticals, Inc.EVP and CFOas of Mar 6, 2026
- ORIC Oric Pharmaceuticals, Inc.Directoras of Jan 6, 2026
- PRLD Prelude Therapeutics IncDirectoras of Jun 13, 2025
- SLRN ACELYRIN, Inc.CFO and CBOas of May 11, 2023
- RARE Ultragenyx Pharmaceutical Inc.CFO & Executive Vice Presidentas of Oct 17, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $3.77M
- 3 filings
- Net
- −$3.77M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Dier Mardi as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
MDGL Madrigal Pharmaceuticals, Inc.
EVP and CFO5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2026 (view filing) | Mar 6 | Same day | Dier MardiEVP and CFO | SSale | −1.98K | $430.87 | −$854.0K | −13.7%12.5K after | 12 lots10b5-1 |
| Mar 2, 2026 (view filing) | Mar 2 | Same day | Dier MardiEVP and CFO | SSale | −1.18K | $427.21 | −$505.4K | −11.3%9.26K after | |
| Dec 3, 2025 (view filing) | Dec 2 | 1 day | Dier MardiEVP and CFO | SSale | −4.17K | $578.34 | −$2.41M | −28.6%10.4K after | 15 lots10b5-1 |
| Mar 12, 2025 (view filing) | Mar 10 | 2 days | Dier MardiSVP and CFO | SSale | −258 | $323.04 | −$83.3K | −2.4%10.4K after | 10b5-1 |
| Mar 5, 2025 (view filing) | Mar 3 | 2 days | Dier MardiSVP and CFO | SSale | −1.96K | $324.96 | −$637.3K | −22.1%6.91K after | 2 lots10b5-1 |
SLRN ACELYRIN, Inc.
CFO and CBO2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 11, 2023 (view filing) | May 9 | 2 days | Dier MardiCFO and CBO | PPurchase | +5.56K | $18.00 | +$100.0K | New position5.56K after | |
| May 11, 2023 (view filing) | May 9 | 2 days | Dier MardiCFO and CBO | PPurchase | +1.75K | $18.00 | +$31.5K | New position875 after | 2 lots |
RARE Ultragenyx Pharmaceutical Inc.
CFO & Executive Vice President4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 17, 2022 (view filing) | Oct 14 | 3 days | Dier MardiCFO & Executive Vice President | SSale | −1.63K | $40.16 | −$65.4K | −2.4%66.7K after | |
| Oct 14, 2022 (view filing) | Oct 12 | 2 days | Dier MardiCFO & Executive Vice President | SSale | −3.48K | $38.22 | −$133.2K | −4.9%68.3K after | |
| Mar 3, 2022 (view filing) | Mar 1-3 | 2 days | Dier MardiCFO & Executive Vice President | SSale | −954 | $65.71 | −$62.7K | −1.8%51.8K after | 2 lots |
| Oct 14, 2021 (view filing) | Oct 12-14 | 2 days | Dier MardiCFO & Executive Vice President | SSale | −6.74K | $82.00 | −$552.5K | −14.8%38.8K after | 2 lots |